| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Immunology, Institute for Cancer Research, The Norwegian Radium Hospital, N-0310 Oslo, Norway [J. L., E. B. S., H. K. B.] and La Jolla Cancer Research Foundation, La Jolla, California 92037 [S. K., J. C. R.]
Normal peripheral blood B lymphocytes undergo spontaneous apoptosis in vitro, and this process is regulated positively and negatively by several immunomodulatory stimuli. We have shown previously that Bcl-2 protein levels are unaltered by these factors, suggesting a Bcl-2-independent regulation of apoptosis in this system. Here, we have investigated the possibility that the three recently identified Bcl-2 homologues, Bax, Bcl-x, and Mcl-1, could be involved instead. Freshly isolated cells expressed both Bax and Mcl-1 protein, but only low levels of Bcl-xL and no detectable Bcl-xS, as determined by Western blot analysis. Upon culture of cells with apoptotic or survival stimuli, Bax and Bcl-xL protein levels remained relatively unchanged. By contrast, Mcl-1 levels decreased markedly in cells undergoing apoptosis in medium and, even more dramatically, after treatment with the apoptotic stimuli transforming growth factor ß1 and forskolin. This decrease was rapid and preceded cell death. Furthermore, all the survival stimuli tested (interleukin 4, anti-IgM antibodies, and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate) prevented the decline in Mcl-1 levels. This striking correlation between cell survival and Mcl-1 expression in peripheral blood B cells suggests the possible involvement of Mcl-1, instead of Bcl-2, in the regulation of apoptosis in these cells. The present study is the first one linking this novel Bcl-2 homologue to the control of cell death in normal cells.
1 This work was supported by The Norwegian Cancer Society.
2 To whom reprint requests should be addressed.
Received 9/29/95. Accepted 11/14/95.
This article has been cited by other articles:
|
|
 |
|
  D. Zhai, C. Jin, C.-w. Shiau, S. Kitada, A. C. Satterthwait, and J. C. Reed Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins Mol. Cancer Ther., June 1, 2008; 7(6): 1639 - 1646. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Petlickovski, L. Laurenti, X. Li, S. Marietti, P. Chiusolo, S. Sica, G. Leone, and D. G. Efremov Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells Blood, June 15, 2005; 105(12): 4820 - 4827. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Liu, H.-W. Peng, Y.-S. Cheng, H. S. Yuan, and H.-F. Yang-Yen Stabilization and Enhancement of the Antiapoptotic Activity of Mcl-1 by TCTP Mol. Cell. Biol., April 15, 2005; 25(8): 3117 - 3126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Real, Y. Cao, R. Wang, Z. Nikolovska-Coleska, J. Sanz-Ortiz, S. Wang, and J. L. Fernandez-Luna Breast Cancer Cells Can Evade Apoptosis-Mediated Selective Killing by a Novel Small Molecule Inhibitor of Bcl-2 Cancer Res., November 1, 2004; 64(21): 7947 - 7953. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Han, L. A. Goldstein, B. R. Gastman, C. J. Froelich, X.-M. Yin, and H. Rabinowich Degradation of Mcl-1 by Granzyme B: IMPLICATIONS FOR Bim-MEDIATED MITOCHONDRIAL APOPTOTIC EVENTS J. Biol. Chem., May 21, 2004; 279(21): 22020 - 22029. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Moshynska, K. Sankaran, P. Pahwa, and A. Saxena Prognostic Significance of a Short Sequence Insertion in the MCL-1 Promoter in Chronic Lymphocytic Leukemia J Natl Cancer Inst, May 5, 2004; 96(9): 673 - 682. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Sly, S. M. Hingley-Wilson, N. E. Reiner, and W. R. McMaster Survival of Mycobacterium tuberculosis in Host Macrophages Involves Resistance to Apoptosis Dependent upon Induction of Antiapoptotic Bcl-2 Family Member Mcl-1 J. Immunol., January 1, 2003; 170(1): 430 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Zhang, F. Li, D. Weidner, Z. H. Mnjoyan, and K. Fujise Physical and Functional Interaction between Myeloid Cell Leukemia 1 Protein (MCL1) and Fortilin. THE POTENTIAL ROLE OF MCL1 AS A FORTILIN CHAPERONE J. Biol. Chem., September 27, 2002; 277(40): 37430 - 37438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Zhang, I. Gojo, and R. G. Fenton Myeloid cell factor-1 is a critical survival factor for multiple myeloma Blood, March 15, 2002; 99(6): 1885 - 1893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Zhou, N. B. Levy, H. Xie, L. Qian, C.-Y. G. Lee, R. D. Gascoyne, and R. W. Craig MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes Blood, June 15, 2001; 97(12): 3902 - 3909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Nör, J. Christensen, J. Liu, M. Peters, D. J. Mooney, R. M. Strieter, and P. J. Polverini Up-Regulation of Bcl-2 in Microvascular Endothelial Cells Enhances Intratumoral Angiogenesis and Accelerates Tumor Growth Cancer Res., March 1, 2001; 61(5): 2183 - 2188. [Abstract] [Full Text]
|
|
|
|
|
|
A. Moreno, M. L. Villar, C. Camara, R. Luque, C. Cespon, P. Gonzalez-Porque, G. Roy, J. Lopez-Jimenez, A. Bootello, and E. R. Santiago Interleukin-6 dimers produced by endothelial cells inhibit apoptosis of B-chronic lymphocytic leukemia cells Blood, January 1, 2001; 97(1): 242 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Moulding, R. V. Giles, D. G. Spiller, M. R. H. White, D. M. Tidd, and S. W. Edwards Apoptosis is rapidly triggered by antisense depletion of MCL-1 in differentiating U937 cells Blood, September 1, 2000; 96(5): 1756 - 1763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-M. Huang, C.-J. Huang, and J. J.-Y. Yen Mcl-1 is a common target of stem cell factor and interleukin-5 for apoptosis prevention activity via MEK/MAPK and PI-3K/Akt pathways Blood, September 1, 2000; 96(5): 1764 - 1771. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Leuenroth, P. S. Grutkoski, A. Ayala, and H. H. Simms The loss of Mcl-1 expression in human polymorphonuclear leukocytes promotes apoptosis J. Leukoc. Biol., July 1, 2000; 68(1): 158 - 166. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. E. Nor, J. Christensen, D. J. Mooney, and P. J. Polverini Vascular Endothelial Growth Factor (VEGF)-Mediated Angiogenesis Is Associated with Enhanced Endothelial Cell Survival and Induction of Bcl-2 Expression Am. J. Pathol., February 1, 1999; 154(2): 375 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Townsend, P. Zhou, L. Qian, C. K. Bieszczad, C. H. Lowrey, A. Yen, and R. W. Craig Regulation of MCL1 through a Serum Response Factor/Elk-1-mediated Mechanism Links Expression of a Viability-promoting Member of the BCL2 Family to the Induction of Hematopoietic Cell Differentiation J. Biol. Chem., January 15, 1999; 274(3): 1801 - 1813. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kitada, J. Andersen, S. Akar, J. M. Zapata, S. Takayama, S. Krajewski, H.-G. Wang, X. Zhang, F. Bullrich, C. M. Croce, et al. Expression of Apoptosis-Regulating Proteins in Chronic Lymphocytic Leukemia: Correlations With In Vitro and In Vivo Chemoresponses Blood, May 1, 1998; 91(9): 3379 - 3389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Consoli, I. El-Tounsi, A. Sandoval, V. Snell, H.-D. Kleine, W. Brown, J. R. Robinson, F. DiRaimondo, W. Plunkett, and M. Andreeff Differential Induction of Apoptosis by Fludarabine Monophosphate in Leukemic B and Normal T Cells in Chronic Lymphocytic Leukemia Blood, March 1, 1998; 91(5): 1742 - 1748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Ghia, V. A. Boussiotis, J. L. Schultze, A. A. Cardoso, D. M. Dorfman, J. G. Gribben, A. S. Freedman, and L. M. Nadler Unbalanced Expression of Bcl-2 Family Proteins in Follicular Lymphoma: Contribution of CD40 Signaling in Promoting Survival Blood, January 1, 1998; 91(1): 244 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. K. Ossina, A. Cannas, V. C. Powers, P. A. Fitzpatrick, J. D. Knight, J. R. Gilbert, E. M. Shekhtman, L. D. Tomei, S. R. Umansky, and M. C. Kiefer Interferon-gamma Modulates a p53-independent Apoptotic Pathway and Apoptosis-related Gene Expression J. Biol. Chem., June 27, 1997; 272(26): 16351 - 16357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lomo, H. K. Blomhoff, S. E. Jacobsen, S. Krajewski, J. C. Reed, and E. B. Smeland Interleukin-13 in Combination With CD40 Ligand Potently Inhibits Apoptosis in Human B Lymphocytes: Upregulation of Bcl-xL and Mcl-1 Blood, June 15, 1997; 89(12): 4415 - 4424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Klampfer, J. Zhang, A. O. Zelenetz, H. Uchida, and S. D. Nimer The AML1/ETO fusion protein activates transcription of BCL-2 PNAS, November 26, 1996; 93(24): 14059 - 14064. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
